^
    4ms
    X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma (clinicaltrials.gov)
    P1, N=20, Recruiting, Immunolight, LLC | N=12 --> 20 | Trial completion date: Aug 2025 --> Mar 2026 | Trial primary completion date: Sep 2024 --> Sep 2025
    Enrollment change • Trial completion date • Trial primary completion date • Metastases
    |
    methoxsalen (X-PACT)
    9ms
    X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma (clinicaltrials.gov)
    P1, N=12, Recruiting, Immunolight, LLC | Trial completion date: Feb 2025 --> Aug 2025 | Trial primary completion date: Mar 2024 --> Sep 2024
    Trial completion date • Trial primary completion date • Metastases
    |
    methoxsalen (X-PACT)
    over1year
    X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma (clinicaltrials.gov)
    P1, N=12, Recruiting, Immunolight, LLC | Trial primary completion date: Mar 2023 --> Mar 2024
    Trial primary completion date • Metastases
    |
    methoxsalen (X-PACT)